Ossiam’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6M | Buy |
7,294
+801
| +12% | +$175K | 0.02% | 308 |
|
|
2025
Q1 | $1.45M | Buy |
6,493
+806
| +14% | +$180K | 0.02% | 269 |
|
|
2024
Q4 | $1.86M | Sell |
5,687
-179
| -3% | -$58.6K | 0.03% | 246 |
|
|
2024
Q3 | $1.76M | Buy |
5,866
+1,945
| +50% | +$584K | 0.03% | 235 |
|
|
2024
Q2 | $1.29M | Buy |
3,921
+1,834
| +88% | +$604K | 0.02% | 307 |
|
|
2024
Q1 | $826K | Buy |
2,087
+935
| +81% | +$370K | 0.01% | 422 |
|
|
2023
Q4 | $406K | Hold |
1,152
| – | – | 0.01% | 502 |
|
|
2023
Q3 | $432K | Sell |
1,152
-739
| -39% | -$277K | 0.01% | 495 |
|
|
2023
Q2 | $723K | Buy |
1,891
+698
| +59% | +$267K | 0.01% | 368 |
|
|
2023
Q1 | $413K | Buy |
1,193
+527
| +79% | +$183K | 0.01% | 413 |
|
|
2022
Q4 | $157K | Hold |
666
| – | – | ﹤0.01% | 507 |
|
|
2022
Q3 | $164K | Buy |
+666
| New | +$164K | ﹤0.01% | 466 |
|
|
2022
Q2 | – | Sell |
-343
| Closed | -$141K | – | 491 |
|
|
2022
Q1 | $141K | Buy |
+343
| New | +$141K | ﹤0.01% | 372 |
|
|
2021
Q4 | – | Sell |
-3,334
| Closed | -$1.42M | – | 480 |
|
|
2021
Q3 | $1.42M | Buy |
3,334
+1,302
| +64% | +$553K | 0.04% | 213 |
|
|
2021
Q2 | $837K | Sell |
2,032
-1,745
| -46% | -$719K | 0.02% | 251 |
|
|
2021
Q1 | $1.06M | Buy |
3,777
+1,226
| +48% | +$345K | 0.03% | 214 |
|
|
2020
Q4 | $723K | Buy |
2,551
+652
| +34% | +$185K | 0.03% | 221 |
|
|
2020
Q3 | $522K | Sell |
1,899
-3,200
| -63% | -$880K | 0.02% | 246 |
|
|
2020
Q2 | $1.16M | Buy |
+5,099
| New | +$1.16M | 0.07% | 163 |
|